Recent insider trading activity from Shankman Michael Elliot, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 15, 2025 | Lexaria Bioscience Corp. | $LEXX | Shankman Michael Elliot | Chief Financial Officer | A | Stock Options | 50000 | $0.00 | 150,000.0000 | 0 | 50.00% | 0.00% |